ABSTRACT By November 2016, a total of 278 patients had completed the original randomized trials, and 264 (95%) enrolled in this open-label extension. Median treatment duration was 274 days (range 1-512) with a mean modal dose of 21 mg/kg/d, and patients received a median of 3 concomitant antiepileptic medications. Adverse events (AEs) occurred in 93.2% …
ABSTRACT A team led by researchers at University of Saskatchewan, Canada, are conducting an open-label Phase 1 clinical study (NCT03024827) called CARE-E. Scientists are exploring the safety and impact of increasing doses of CBD-enriched cannabis herbal extract (CHE) used as add-on therapy in up 28 children (ages 1 to 10) with epileptic encephalopathy resistant to …
ABSTRACT The median frequency of convulsive seizures per month decreased from 12.4 to 5.9 with cannabidiol, as compared with a decrease from 14.9 to 14.1 with placebo (adjusted median difference between the cannabidiol group and the placebo group in change in seizure frequency, −22.8 percentage points; 95% confidence interval [CI], −41.1 to −5.4; P=0.01). The …
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome Read More »
Be the first to receive exciting news, features, and special offers from MCBDshop.com
MCBD is an organic line of CBD wellness products made with the highest quality hemp CBD on the market. Our full spectrum hemp cbd oil is naturally thc-free, premium grade and Farm Bill compliant. Our full spectrum CBD products are thc-free, organic, all-natural and formulated with our patented nanoemulsification technology making our cbd products more effective.
M Brands Inc. 222 Yamato Rd. 106-300 Boca Raton, FL 33431 USA support@mcbdshop.com 561.288.0606 © 2020 All Rights Reserved | Privacy Policy | Terms and Conditions | Deliveries and Returns
